255 related articles for article (PubMed ID: 1673382)
1. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
Gan KN; Smolen A; Eckerson HW; La Du BN
Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
[TBL] [Abstract][Full Text] [Related]
3. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
Rodrigo L; Gil F; Hernández AF; Pla A
Chem Biol Interact; 1999 May; 119-120():263-75. PubMed ID: 10421461
[TBL] [Abstract][Full Text] [Related]
4. The polymorphic paraoxonase/arylesterase isozymes of human serum.
La Du BN; Eckerson HW
Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
[TBL] [Abstract][Full Text] [Related]
5. The human serum paraoxonase/arylesterase polymorphism.
Eckerson HW; Wyte CM; La Du BN
Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
[TBL] [Abstract][Full Text] [Related]
6. Studies on human serum paraoxonase/arylesterase.
La Du BN; Adkins S; Kuo CL; Lipsig D
Chem Biol Interact; 1993 Jun; 87(1-3):25-34. PubMed ID: 8393742
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase polymorphism in rabbits.
Zech R; Severin RM; Chemnitius JM; Nebendahl K
Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
[TBL] [Abstract][Full Text] [Related]
8. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.
Haagen L; Brock A
Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):391-5. PubMed ID: 1525262
[TBL] [Abstract][Full Text] [Related]
9. High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Dirican M; Taş S; Sarandöl E
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):833-7. PubMed ID: 17645625
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.
Karakaya A; Suzen S; Sardas S; Karakaya AE; Vural N
Pharmacogenetics; 1991 Oct; 1(1):58-61. PubMed ID: 1668963
[TBL] [Abstract][Full Text] [Related]
11. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.
Ortigoza-Ferado J; Richter RJ; Hornung SK; Motulsky AG; Furlong CE
Am J Hum Genet; 1984 Mar; 36(2):295-305. PubMed ID: 6324579
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation.
Reiner E; Svedruzic D; Simeon-Rudolf V; Lipovac V; Gavella M; Mrzljak V
Chem Biol Interact; 1999 May; 119-120():405-11. PubMed ID: 10421477
[TBL] [Abstract][Full Text] [Related]
13. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
Simeon V; Pavković E
Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of hemolymph juvenile hormone esterase from the cricket, Gryllus assimilis.
Zera AJ; Sanger T; Hanes J; Harshman L
Arch Insect Biochem Physiol; 2002 Jan; 49(1):41-55. PubMed ID: 11754093
[TBL] [Abstract][Full Text] [Related]
15. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Koc A; Cengiz M; Ozdemir ZC; Celik H
Pediatr Hematol Oncol; 2012 May; 29(4):345-53. PubMed ID: 22568797
[TBL] [Abstract][Full Text] [Related]
17. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
18. Molecular weight and substrate characteristics of human serum arylesterase following purification by immuno-affinity chromatography.
Tanaka-Kawai H; Yomoda S
Clin Chim Acta; 1993 Jun; 215(2):127-38. PubMed ID: 8403430
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.
Aviram M; Billecke S; Sorenson R; Bisgaier C; Newton R; Rosenblat M; Erogul J; Hsu C; Dunlop C; La Du B
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1617-24. PubMed ID: 9763535
[TBL] [Abstract][Full Text] [Related]
20. Enzyme visualization with partially dehydrated agarose substrate layers: detection of paraoxonase after thin-layer isoelectric focusing in agarose.
Haas A; Geldmacher-von Mallinckrodt M
Electrophoresis; 1990 Aug; 11(8):621-6. PubMed ID: 1963139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
